FDA Official Sees Drug Approvals Rising
A top agency official said the FDA is seeing a rising number of new drugs ready for approval and expects a gradual increase in medicines that reach the market.

FDA Grants Fast Track Designation To Bayer's Investigational Compound Regorafenib For The Treatment Of ...
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments ...